Welcome to our dedicated page for Ayro SEC filings (Ticker: AYRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AYRO (AYRO) SEC filings page on Stock Titan provides access to regulatory documents that trace the company’s transition into StableX Technologies, Inc. and its evolving strategies in electric vehicles, capital markets, and digital assets. Filings labeled under AYRO, Inc. and later StableX Technologies, Inc. include multiple Form 8-K current reports and a definitive proxy statement on Schedule 14A (DEF 14A), each detailing specific corporate actions.
Key 8-K filings describe events such as the June 2025 1-for-16 reverse stock split of common stock, the July 2025 rights agreement establishing preferred share purchase rights tied to Series A Junior Participating Preferred Stock, and the August 2025 Securities Purchase Agreement for Series I Convertible Preferred Stock and associated warrants. Additional 8-Ks outline amendments to existing Series H-7 preferred stock and warrants, the August 2025 name change from AYRO, Inc. to StableX Technologies, Inc., and the corresponding Nasdaq ticker change from AYRO to SBLX.
Later filings under the StableX name include 8-Ks reporting changes in the company’s independent registered public accounting firm, stockholder approval of an amendment to the long-term incentive plan, and equity awards to executives and directors. These documents also reference previously disclosed material weaknesses in internal control over financial reporting, providing insight into governance and risk factors discussed in the company’s Annual Report for the fiscal year ended December 31, 2024.
The DEF 14A proxy statement dated September 18, 2025, details proposals presented at a special meeting of stockholders, including approval of the issuance of common stock underlying Series I Preferred Stock and warrants and an increase in shares authorized under the long-term incentive plan. On Stock Titan, these filings are supplemented with AI-powered summaries that highlight the main points of each document, helping readers quickly understand complex topics such as preferred stock terms, warrant amendments, voting results, and capital structure changes without reading every page.
For historical research on AYRO and for current information on StableX Technologies, Inc. (SBLX), this filings page offers a structured view of material events, corporate actions, and governance decisions as reported to the U.S. Securities and Exchange Commission.
AYRO, Inc. entered into a Securities Purchase Agreement to issue a newly designated Series I Convertible Preferred Stock and related warrants to certain accredited investors. The Company agreed to sell an aggregate of 7,000 shares of Series I Preferred Stock with a stated value of $1,000 per share, initially convertible into up to 875,000 shares of common stock at an initial conversion price of $8.00 per share. The transaction also includes warrants to acquire up to an aggregate of 875,000 shares of common stock at an exercise price of $8.00 per share. The Company filed the Certificate of Designations creating the Series I Preferred Stock.
The Company also filed an amendment to its Series H-7 Certificate of Designations that, as disclosed, extends the maturity date to February 4, 2027, revises payment dates and payable amounts for dividends and installment amounts, modifies the definition of "Excluded Securities," and adjusts the schedule of installment dates. Series H-7 holders provided waivers and consents and the Company filed the related Certificate of Amendment. These actions change certain security rights and provide for the issuance of the Series I securities referenced above.
AYRO (NASDAQ:AYRO) filed an 8-K on June 27 2025 disclosing that it filed a Certificate of Amendment on June 23 2025 to effect a 1-for-16 reverse stock split of its common stock, effective 4:05 p.m. ET on June 25 2025.
The split, approved by shareholders at the May 19 2025 annual meeting, automatically combined every 16 shares into one. Fractional shares are rounded up; the par value remains $0.0001 and authorized shares remain 1.2 billion. Proportional adjustments apply to all outstanding equity awards, warrants and convertible securities.
Split-adjusted trading began on Nasdaq on June 26 2025 under the unchanged ticker AYRO; the new CUSIP is 054748306. No other material modifications were reported.